Patent SG-11201806577U-A (SG)
Title: Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
Inventor: SCHOOR OLIVER
IPC: C07K14/47
Filed: 2017-02-17
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 24 August 2017 (24.08.2017) WIPO I PCT (10) International Publication Number WO 2017/140897 Al 1111111111111101110111111111110101111101110101111111111110111101111111111111110111111 (51) International Patent Classification: CO7K 14/47 (2006.01) (21) International Application Number: PCT/EP2017/053704 (22) International Filing Date: 17 February 2017 (17.02.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 1602918.3 19 February 2016 (19.02.2016) GB 62/297,495 19 February 2016 (19.02.2016) US (71) Applicant: IMMATICS BIOTECHNOLOGIES GMBH [DE/DE]; Paul-Ehrlich-Strasse 15, 72076 Tiibingen (DE). (72) Inventors: SCHOOR, Oliver; Eichhaldenstrasse 19, 72074 Tiibingen (DE). MAHR, Andrea; Kirschenweg 22, 72076 Tiibingen (DE). WEINSCHENK, Toni; Im Mor- genrain 15, 73773 Aichwald (DE). WIEBE, Anita; Quel- lenstrasse 49, 72124 Ruebgarten (DE). FRITSCHE, Jens; Larchenweg 11, 72144 Dusslingen (DE). SINGH, Har- preet; 2215 Dryden Rd, Houston, Texas 77030 (US). (74) Agent: KRAUSS, Jan B.; BOEHMERT & BOEHMERT, Pettenkoferstrasse 20 - 22, 80336 Munich (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a)) W O 20 17 / 140897 Al (54) Title: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS (57) : The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associ- ated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active phar- maceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.